Approximately 60% of melanomas harbor an activating BRAF (v-raf murine sarcoma viral oncogene homolog B1) mutation V600E (changing valine to glutamic acid and being highly predominant over other infrequent BRAF mutations). This evidence concerns the gene BRAF and melanoma.